Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Globus Medical, which has a market cap of $11.9bn, will buy all Nevro ... stimulator systems, for example, gained access to a wider market after winning FDA approval for non-surgical back pain ...

Nevro Corp. engages in the development of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops ...

The acquisition of Vyrsa Technologies in December 2023 enabled Nevro to introduce a complementary line of products aimed at treating chronic pain caused by the SI joint. We remain optimistic about ...

life-changing solutions for the treatment of chronic pain. “We are excited to begin the journey of accelerating market penetration of Nevro’s differentiated high-frequency technology and ...

Nevro’s comprehensive HFX™ spinal cord stimulation (SCS) platform includes the Senza® SCS system and support services for the treatment of chronic pain of the trunk and limb and painful ...